Lipocine Announces Presentations at the 21st Annual Fall Meeting of the Sexual Medicine Society of North America

SALT LAKE CITY, Oct. 14, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, today announced it will present results from studies suggesting that low testosterone levels may play an important role on the clinical outcomes of COVID-19 in men as well as the safety and efficacy of TLANDO™, an oral testosterone replacement therapy without a dose titration requirement, at the 21st Annual Fall Scientific Meeting of the Sexual Medicine Society of North America (“SMSNA”). Lipocine will outline the possible mechanisms and clinical evidence that suggests men with low testosterone have poor COVID-19 outcomes, and the rationale of using an oral testosterone therapy for men with COVID-19. Results from the previously completed dose validation (“DV”) study of a fixed dose TLANDO in hypogonadal males will also be presented at the meeting.  The presentations will take place virtually on November 9, 2020

Read More

Japan firms fall woefully short of meeting government goals on women in management – Reuters poll

TOKYO (Reuters) – About one-fifth of Japanese companies have no female managers and most say women account for less than 10% of management, a Reuters monthly poll found, highlighting the struggle for the government’s “womenomics” drive to make headway.

FILE PHOTO: A woman wearing a protective face mask uses an escalator in a quiet business district on the first working day after the Golden Week holiday, following the coronavirus disease (COVID-19) outbreak, in Tokyo, Japan, May 7,2020.REUTERS/Kim Kyung-Hoon

The survey results come as Japan is seen to delay its target this year to raise the share of women in leadership posts to 30% as part of the government’s campaign to empower women, dubbed “womenomics”, and cope with Japan’s ageing population.

The Reuters Corporate Survey, conducted Sept. 29-Oct. 8, found 71% of Japanese firms said women accounted for less than 10% of management, while 17% had no female managers at all.

Read More

Japan firms fall woefully short of meeting government goals on women in management: Reuters poll

By Tetsushi Kajimoto

TOKYO (Reuters) – About one-fifth of Japanese companies have no female managers and most say women account for less than 10% of management, a Reuters monthly poll found, highlighting the struggle for the government’s “womenomics” drive to make headway.

The survey results come as Japan is seen to delay its target this year to raise the share of women in leadership posts to 30% as part of the government’s campaign to empower women, dubbed “womenomics”, and cope with Japan’s ageing population.

The Reuters Corporate Survey, conducted Sept. 29-Oct. 8, found 71% of Japanese firms said women accounted for less than 10% of management, while 17% had no female managers at all.

Asked how much scope there was to increase female managers, 55% said by around 10%, a quarter said by about 20%, one in 10 firms said by around 30%, while 5% saw no room for that.

Read More

In deadly year, new U.S. attorney, Albany law enforcement meeting over gun violence

ALBANY — The region’s new U.S. attorney will meet with local law enforcement officials Tuesday as they plot ways to combat gun violence.

After meeting at police headquarters, acting U.S. Attorney Antoinette T. Bacon will hold a news conference with local law enforcement officials including Albany Police Chief Eric Hawkins to discuss joint efforts to address gun violence. Mayor Kathy Sheehan, who is in quarantine after being around Binghamton Mayor Richard David who tested positive for COVID-19 last week, is expected to hold a separate news briefing.

The Bacon’s meeting with police will take place in the midst of one of the region’s most violent years. More than 100 people have been shot in Albany. The majority of the city’s 16 homicide victims were shot.

In Troy, a city that with a population of 49,374 that is roughly half the size of Albany, the violence has been staggering with 13

Read More

Lake George board, superintendent violated open meeting law, judge rules

LAKE GEORGE – A ruling from a state Supreme Court justice determined the central school district’s superintendent and board of education violated an open meetings law, but did not give Lake George United for Education what they wanted — their assistant principal back.

Justice Thomas Nolan’s Sept. 30 decision concluded that the breach of the open meetings law doesn’t void or reverse the board’s March 2018 resolution to remove Assistant Principal Cody Conley in favor of hiring a curriculum coordinator.

“The topic that was discussed was one permitted to be discussed in executive session,” Nolan wrote in his decision. “This does not evince, in this court’s judgment, either conscious or malicious or deliberate effort by the Board to violate the law or that the Board has engaged in a documented, persistent pattern of such violations.”

The decision, as first reported by the Post-Star of Glens Falls, the judge declined to

Read More

Castle Biosciences Presents Data at the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting


Castle Biosciences, Inc. (Nasdaq: CSTL), a skin cancer diagnostics company providing personalized genomic information to improve cancer treatment decisions, today announced that its data were featured in two oral presentations during the 2020 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting, Oct. 9-11, 2020.


DecisionDx®-Melanoma: Skin Cancer and Reconstruction Session; Friday, October 9, 2020


“Cutaneous Melanoma Prognostic Model Combining 31-gene Expression Profile and Sentinel Lymph Node Biopsy” was presented by Aaron Farberg, M.D., Baylor University Medical Center, Dallas, Texas.


DecisionDx-Melanoma is a gene expression profile test that uses an individual patient’s tumor biology to predict individual risk of cutaneous melanoma metastasis or recurrence, as well as sentinel lymph node positivity, independent of traditional staging factors.


“As most sentinel lymph node biopsies are negative, there is a need to identify which melanoma patients can forgo sentinel lymph node biopsy (SNLB),” said Dr.

Read More

KAHR Announces Oral Presentation at the 62nd American Society of Hematology (ASH) Annual Meeting

JERUSALEM, Oct. 12, 2020 /PRNewswire/ — KAHR, a cancer immunotherapy company developing novel multifunctional immuno-recruitment proteins, today announced that an abstract reporting preclinical data for DSP107, a second generation CD47x41BB targeting compound for the treatment of solid tumors and hematological malignancies, has been accepted for an oral presentation at the 62nd American Society of Hematology (ASH) Annual Meeting and Exposition, taking place virtually from December 5-8, 2020.

“The ASH Annual Meeting will be an important opportunity to present mechanistic studies and extensive in vitro and in vivo results from our novel CD47x41BB clinical stage drug candidate,” said Yaron Pereg, Ph.D., Chief Executive Officer of KAHR. “We look forward to advancing the clinical development of this novel therapy.”

The following abstract will be posted on the ASH website on November 5, 2020, at 9:00 a.m. ET:

Title: DSP107, a Novel Bi-Functional Fusion Protein That Combines Inhibition

Read More

Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting

IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ — Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.

The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows.

Oral presentations include:

  • Patient Satisfaction Following Chin Augmentation With Hyaluronic Acid Fillers: A Pooled Analysis
  • Authors: Joely Kaufman, Patricia Ogilvie, Kenneth Beer, Alexander Rivkin, Sarah Baradaran, Andrew Schumacher
  • Presenter: Joely Kaufman, MD
  • Saturday, October 10th, 11:27 a.m.
  • Treatment of Upper Facial Lines With OnabotulinumtoxinA Results in Long-Lasting Efficacy and Patient Satisfaction
    • Authors: Joel L. Cohen, Koenraad De Boulle, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Patricia Ogilvie, Julie Garcia, Sara Sangha
    • Presenter: Joel L. Cohen, MD
    • Sunday, October
    Read More

    Allergan Aesthetics To Present Data From 4 Abstracts At The 2020 American Society For Dermatologic Surgery Virtual Meeting | Nachricht

    IRVINE, Calif., Oct. 9, 2020 /PRNewswire/ –Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced today that it will present 4 abstracts at the annual American Society for Dermatologic Surgery (ASDS) virtual meeting from October 9-11, 2020.

    The scheduled times (noted in local Eastern Standard Time) of the presentations, titles and authors are as follows.

    Oral presentations include:

    • Patient Satisfaction Following Chin Augmentation With Hyaluronic Acid Fillers: A Pooled Analysis
    • Authors: Joely Kaufman, Patricia Ogilvie, Kenneth Beer, Alexander Rivkin, Sarah Baradaran, Andrew Schumacher
    • Presenter: Joely Kaufman, MD
    • Saturday, October 10th, 11:27 a.m.
  • Treatment of Upper Facial Lines With OnabotulinumtoxinA Results in Long-Lasting Efficacy and Patient Satisfaction
    • Authors: Joel L. Cohen, Koenraad De Boulle, Steven Fagien, Jean Carruthers, Sue Ellen Cox, Patricia Ogilvie, Julie Garcia, Sara Sangha
    • Presenter: Joel L. Cohen, MD
    • Sunday, October 11
    Read More

    Endo Aesthetics Data to be Featured in Five Presentations at the American Society for Dermatologic Surgery’s Annual Meeting (ASDS)

    DUBLIN, Oct. 9, 2020 /PRNewswire/ — Endo International plc (NASDAQ:ENDP) today announced that data relevant to the use of Endo Aesthetics’ Qwo™ (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women will be featured during the American Society for Dermatologic Surgery’s Annual Meeting (ASDS). These data will be highlighted in three posters and two oral presentations during the virtual meeting taking place October 9 – 11, 2020.

    Oral Presentations

    On Friday, October 9th a presentation titled “Results From a 1000+ Subject Survey Assessing Satisfaction With a Hypothetical 1-Point Improvement on the Validated Patient-Reported Photonumeric Cellulite Severity Scale (PR-PCSS) Analysis,” will be given by Sabrina Fabi, M.D., a board-certified dermatologist in California. Dr. Fabi will share results from a study designed to determine if a 1-point improvement in PR-PCSS score is a clinically meaningful outcome and will highlight the

    Read More